Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Pathologica
|
August 16, 2011
Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up
A Gazzola, E Sabattini, C Mannu, et al.
Leukemia
|
April 20, 2007
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
B Falini, D Lenze, R Hasserjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2008
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
P L Zinzani, M Tani, S Fanti, et al.
Leukemia
|
December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
S A Pileri, S Ascani, M C Cox, et al.
Blood Cancer Journal
|
November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
M A Laginestra, P P Piccaluga, F Fuligni, et al.
Molecular Phylogenetics and Evolution
|
April 21, 2026
Phylogenomics of melastomataceae: rooting out discordance across organellar and nuclear genomes
Monique Romeiro Brito, Léo-Paul M J Dagallier, Lucas F Bacci, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Pathologica
|
August 16, 2011
Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up
A Gazzola, E Sabattini, C Mannu, et al.
Leukemia
|
April 20, 2007
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
B Falini, D Lenze, R Hasserjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2008
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
P L Zinzani, M Tani, S Fanti, et al.
Leukemia
|
December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
S A Pileri, S Ascani, M C Cox, et al.
Blood Cancer Journal
|
November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
M A Laginestra, P P Piccaluga, F Fuligni, et al.
Molecular Phylogenetics and Evolution
|
April 21, 2026
Phylogenomics of melastomataceae: rooting out discordance across organellar and nuclear genomes
Monique Romeiro Brito, Léo-Paul M J Dagallier, Lucas F Bacci, et al.
Page
of 4